According to the company, all medications are administered as once-weekly injections, and pricing includes the prescription process, telehealth visits, and free shipping
Semaglutide, a GLP-1 receptor agonist, has emerged as a powerful tool for weight loss, but patients taking blood pressure medications naturally question whether these therapies can coexist safely
Its ability to activate GLP-1, glucagon, and GIP receptor pathways simultaneously has made retatrutide an important compound in modern metabolic research involving glycemic control, energy expenditure, and obesity-related signaling pathways
Researchers conducted a retrospective cohort study using the TriNetX Global Collaborative Network and identified adults with obesity who underwent TAVR between January 2020 and January 2025, grouping them based on tirzepatide use